-transparent.png){kind=logo}
We conducted a retrospective study including 517 patients with invasive breast cancer classified pT1 less than 20mm. We estimated the relevance of bone scan in the screening of metastases at the time of primary presentation, as well as the costs incurred by such a screening. Postoperative systematic bone scan did not detect the two cases of synchronous bone metastases in this population. No bone metastasis was detected in groups with the highest metastatic risks (low profitability for all pT1 classified cancers). Bone scan's rate of false positive was high (17%). The global cost was estimated at 110,770 euros, that was 215 euros per patient (208 to 232 euros in the risk groups).
E Simon, and
H Marret, and
I Barillot, and
A Bougnoux, and
N Hajjaji, and
G Body
April 1997,
British journal of urology,
E Simon, and
H Marret, and
I Barillot, and
A Bougnoux, and
N Hajjaji, and
G Body
March 2013,
Surgical endoscopy,
E Simon, and
H Marret, and
I Barillot, and
A Bougnoux, and
N Hajjaji, and
G Body
September 2006,
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology,
E Simon, and
H Marret, and
I Barillot, and
A Bougnoux, and
N Hajjaji, and
G Body
June 2008,
Annals of surgical oncology,
E Simon, and
H Marret, and
I Barillot, and
A Bougnoux, and
N Hajjaji, and
G Body
August 2005,
Cancer,
E Simon, and
H Marret, and
I Barillot, and
A Bougnoux, and
N Hajjaji, and
G Body
March 2003,
La Tunisie medicale,
E Simon, and
H Marret, and
I Barillot, and
A Bougnoux, and
N Hajjaji, and
G Body
December 1995,
European journal of cancer (Oxford, England : 1990),
E Simon, and
H Marret, and
I Barillot, and
A Bougnoux, and
N Hajjaji, and
G Body
January 1998,
The American surgeon,
E Simon, and
H Marret, and
I Barillot, and
A Bougnoux, and
N Hajjaji, and
G Body
June 2022,
Nuclear medicine communications,
E Simon, and
H Marret, and
I Barillot, and
A Bougnoux, and
N Hajjaji, and
G Body
January 1980,
Bulletin du cancer,
